Lead sponsor
Taipei Veterans General Hospital, Taiwan
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
1
Active
260
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
2
Not applicable
1
Trials by status
Not yet recruiting
1
Unknown
2
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic PatientsHbA1c 7-9%Ph 4Unknown160
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms—Ph 4Not yet recruiting60
The Efficacy of Mallya in Type 2 Diabetes Transiting From Oral Antidiabetic Drugs to iGlarLixiHbA1c ≥7%not applicableUnknown40